ARGA Investment Management LP Acquires Shares of 13,739 Integer Holdings Corporation $ITGR

ARGA Investment Management LP acquired a new position in shares of Integer Holdings Corporation (NYSE:ITGR) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 13,739 shares of the medical equipment provider’s stock, valued at approximately $1,209,000.

Several other institutional investors and hedge funds also recently modified their holdings of the stock. Salomon & Ludwin LLC grew its stake in shares of Integer by 46.8% in the fourth quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 118 shares in the last quarter. TD Private Client Wealth LLC lifted its position in Integer by 1,037.5% during the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 415 shares in the last quarter. Parkside Financial Bank & Trust lifted its position in Integer by 135.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 267 shares in the last quarter. Arax Advisory Partners boosted its holdings in Integer by 2,489.5% in the 4th quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 473 shares during the period. Finally, Farther Finance Advisors LLC boosted its holdings in Integer by 193.2% in the 4th quarter. Farther Finance Advisors LLC now owns 519 shares of the medical equipment provider’s stock worth $41,000 after acquiring an additional 342 shares during the period. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Citigroup lifted their price objective on shares of Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a research note on Wednesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Integer in a report on Thursday, June 18th. Zacks Research downgraded shares of Integer from a “hold” rating to a “strong sell” rating in a research note on Monday, May 11th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $97.00 price objective (up from $87.00) on shares of Integer in a report on Friday, May 1st. Four equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $99.29.

Integer Stock Performance

Integer stock opened at $93.51 on Friday. Integer Holdings Corporation has a 52 week low of $62.00 and a 52 week high of $121.76. The company has a current ratio of 3.75, a quick ratio of 2.38 and a debt-to-equity ratio of 0.77. The stock has a market cap of $3.18 billion, a P/E ratio of 23.32, a price-to-earnings-growth ratio of 2.19 and a beta of 0.64. The stock has a 50 day moving average of $90.67 and a 200-day moving average of $86.89.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 EPS for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). The company had revenue of $439.58 million for the quarter, compared to the consensus estimate of $426.48 million. Integer had a net margin of 7.64% and a return on equity of 12.83%. The company’s revenue was up .5% compared to the same quarter last year. During the same quarter last year, the company earned $1.31 earnings per share. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. On average, analysts expect that Integer Holdings Corporation will post 6.04 EPS for the current fiscal year.

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.